EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Willingness to Accept a Locally Manufactured COVID-19 Vaccine in Lagos, Nigeria: A Cross-Sectional Survey and Demographic Predictors

Taiwo Opeyemi Aremu, Olihe Nnenna Okoro, Caroline Gaither, S. Bruce Benson, Drissa M. Toure, Jon C. Schommer

COVID · 08.08.2026 · 6 (8) · 146

DOI: 10.3390/covid6080146 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift COVID, online erschienen am 08.08.2026. Verfasst von Taiwo Opeyemi Aremu und 5 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Local vaccine manufacturing is being pursued across Africa to improve pandemic preparedness and reduce reliance on imports. In Nigeria, where COVID-19 vaccines were largely imported, willingness to accept locally produced vaccines is important for sustainable domestic production. The objective of this study was to estimate willingness to accept a locally manufactured COVID-19 vaccine among adults in Lagos, Nigeria, and to identify demographic predictors.

Methods

We conducted a cross-sectional survey of adults in Lagos State from 7 September to 16 September 2024, using a questionnaire administered in four open-air markets. The primary outcome was willingness to accept a COVID-19 vaccine manufactured in Nigeria (yes/no). We summarized respondent characteristics, tested bivariate associations using chi-square tests, and estimated adjusted odds ratios (AORs) using multivariable logistic regression. Model calibration and discrimination were assessed using Hosmer–Lemeshow testing and the area under the ROC curve (AUC).

Results

Of 388 consenting respondents, 335 provided complete data (86.3%). Respondents were predominantly female (60.6%); the largest age groups were 25–34 (30.2%) and 35–44 (28.4%) years. Overall, 75.8% reported willingness to accept a Nigerian-made COVID-19 vaccine. Willingness differed by age group (p = 0.0028; trend p = 0.0002) and religion (p = 0.0403). In adjusted models, respondents aged 45–54 years (aOR 6.54; 95% CI: 1.73–24.79) and 55–64 years (aOR 4.97; 95% CI: 1.05–23.55) had higher odds of acceptance than those aged 18–24 years. Christian affiliation was associated with lower odds than Muslim affiliation (aOR 0.41; 95% CI: 0.20–0.83). Discrimination was acceptable (AUC 0.75; 95% CI: 0.69–0.80).

Conclusions

Most respondents were willing to accept a Nigerian-made COVID-19 vaccine, suggesting demand-side readiness. Confidence-building strategies tailored to younger adults and implemented with faith-based and community institutions may support uptake of locally produced vaccines.

Zitieren

APA

Aremu, T. O., Okoro, O. N., Gaither, C., Benson, S. B., Toure, D. M., & Schommer, J. C. (2026). Willingness to Accept a Locally Manufactured COVID-19 Vaccine in Lagos, Nigeria: A Cross-Sectional Survey and Demographic Predictors. COVID, 6(8), 146. https://doi.org/10.3390/covid6080146

Vancouver

Aremu TO, Okoro ON, Gaither C, Benson SB, Toure DM, Schommer JC. Willingness to Accept a Locally Manufactured COVID-19 Vaccine in Lagos, Nigeria: A Cross-Sectional Survey and Demographic Predictors. COVID. 2026;6(8):146. doi:10.3390/covid6080146

BibTeX
@article{Aremu2026,
  author = {Aremu, Taiwo Opeyemi and Okoro, Olihe Nnenna and Gaither, Caroline and Benson, S. Bruce and Toure, Drissa M. and Schommer, Jon C.},
  title = {Willingness to Accept a Locally Manufactured COVID-19 Vaccine in Lagos, Nigeria: A Cross-Sectional Survey and Demographic Predictors},
  journal = {COVID},
  year = {2026},
  volume = {6},
  number = {8},
  pages = {146},
  doi = {10.3390/covid6080146}
}
Kostenlos starten →